FDA claims trial 'manipulation' tainted approval of ChemoCentryx drug
FDA claims trial 'manipulation' tainted approval of ChemoCentryx drug
FDA claims trial 'manipulation' tainted approval of ChemoCentryx drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.